Optimising selective deuteration of proteins for 2D 1H NMR detection and assignment studies Application to the Phe residues of Lactobacillus casei dihydrofolate reductase  by Feeney, J. et al.
Volume 248, number 1,2, 57-61 FEB 07071 May 1989 
Optimising selective deuteration of proteins for 2D lH NMR 
detection and assignment studies 
Application to the Phe residues of LactobaciZhs casei dihydrofolate reductase 
J. Feeney, B. Birdsall, J. Akiboye, S.J.B. Tendler, J. Jimtnez Barbero, G. Ostler, J.R.P. Arnold*, 
G.C.K. Roberts*, A. Kiihn+ and K. Roth+ 
Physical Biochemistry Division, NIiUR, Mill Hill, London NW7 IAA, *Biochemistry Department, University of Leicester 
University Road, Leicester LEl 7RH, England and + Institut fiir Organische Chemie, Freie Universitdt, Berlin WE 02. 
Germany 
Received 8March 1989 
A selectively deuterated ihydrofoiate reductase from L. cusei has been prepared containing partially deuterated aromatic 
amino acids. This provides simplified 2D NMR spectra and allows signals from all 8 Phe residues to be identified. The 
pattern of deuteration is such that (i) the only cross-peaks detected in the aromatic region of the 2D COSY spectrum 
are those between the Phe 2’,6’ and 3’,5’ protons and (ii) chemical shift degeneracy in the aromatic region is removed 
thus allowing unambiguous assignment of cross-peaks in 2D NOESY spectra required for specific assignment purposes. 
NMR, 2D; Dihydrofolate reductase; Selective deuteration 
1. INTRODUCTION 
NMR spectroscopy can be used to obtain detail- 
ed information about interactions, conformations 
and dynamic processes in protein-ligand complexes 
in solution. However, in order to extract such in- 
formation from NMR spectra it is necessary to 
assign the NMR signals to specific nuclei in the 
complex. The availability of high-field NMR spec- 
trometers and the development of two-dimensional 
multipulse NMR experiments has considerably 
simplified this process, and the ‘H spectra of many 
small proteins can now be completely assigned by 
using the sequential assignment procedures 
pioneered by Wiithrich et al. (see [l] and references 
therein). However, for larger proteins (M,> 
15 OOO), the increased complexity of the spectra, 
with inevitable degeneracy in chemical shifts, 
militates against the simple application of the 
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direct sequential assignment method. Chemical 
shift degeneracies not only make it difficult to 
assign the signals to residue types (in 2D correlation 
experiments such as COSY and HOHAHA) but 
also complicate the analysis of 2D NOESY ex- 
periments. This is particularly difficult when one 
proton has NOE connectivities to several others; 
any ambiguity in the assignment of the nuclei con- 
tributing to the NOESY cross-peaks makes it very 
difficult to apply the sequential assignment method 
in a straightforward manner. Although 2D 
RELAYED NOESY [2] or 3D methods (for exam- 
ple, combining HOHAHA and NOESY [2]) will 
contribute to removing some of these ambiguities, 
the short 7’~ values of larger proteins make these 
methods difficult to use. Isotopic labelling pro- 
vides an obvious way of simplifying complex pro- 
tein spectra [3-111 and it now seems likely that a 
combination of these methods with the available 
2D NMR experiments will provide the basis for 
assigning ‘H spectra of larger proteins. For exam- 
ple, Le Masters and Richards [lo] have examined 
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partially perdeuterated proteins and obtained im- 
proved 2D COSY spectra: in these experiments the 
level of non-selective deuteration was arranged 
such that only isolated pairs of protons interact in 
any one molecule thus simplifying the multiplicity 
on the detected cross-peaks in the 2D COSY spec- 
tra. Others have chosen to adopt more selective ap- 
proaches to deuteration. 
While the simplest method of examining an ex- 
tensively deuterated protein containing only one 
non-deuterated amino acid residue type provides 
an unambiguous assignment of the signals to a 
residue type it does not allow one to make specific 
assignments to sequence positions. In order to do 
this it is necessary to make NOE connections be- 
tween protons in several different residues. For this 
one needs to aim for a pattern of selective deutera- 
tion that is sufficient to remove the chemical shift 
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Fig. 1. Aromatic region of the 2D COSY ‘H contour plot for the dihydrofolate reductase-methotrexate complex recorded at 308 K and 
500 MHz with a Bruker AM500 spectrometer. (a) Non-deuterated enzyme. (b) Selectively deuterated enzyme incorporating the selective- 
ly deuterated aromatic acids (I-IV). The COSY spectra were obtained in the absolute value mode using a (90-tr-90-t&). pulse se- 
quence with a ldstep phase cycle to select N-type peaks and to suppress quadrature images and axial peaks [16]. 2D experiments were 
carried out with the carrier frequency placed at the centre of the spectrum using quadrature detection in both dimensions. The Hz0 peak 
was decreased by irradiating it during the relaxation delay (0.8 s). The data was multiplied by a sine bell squared window function, un- 
shifted, in each dimension. The ‘H NMR chemical shift reference, dioxane (1 mM) is 3.75 ppm downfield of 5,5-di- 
methyl-S-silapentane-2-sulfonate at 308 K. In spectrum (a) 308 scans were acquired and 1024 data points used in tz for each of the 256 
tl values. The spectral width was 6410 Hz (12.8 ppm) giving a digital resolution of 6.3 Hz/point in FZ and the time domain data matrix 
was zero-filled to 1024 points. The enzyme-methotrexate complex was 1.0 mM in D20 containing 50 mM potassium 
phosphate1500 mM KCI. In spectrum (b) 144 scans were acquired and 2048 data points were used in t2 for each of the 384 t1 values. 
The spectral width was 6410 Hz (12.8 ppm) giving a digital resolution of 3.1 Hz/point. The time domain data matrix was again zero- 
filled to 1024 points. The deuterated enzyme-methotrexate complex was 1 .O mM in DzO buffer. 
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ambiguities but which retains enough protons to 
allow the necessary NOE connections to be made 
for specific assignment purposes. 
In the aromatic region of the ‘H spectrum of di- 
hydrofolate reductase (i% 18 300) there is a great 
deal of chemical shift degeneracy. In previous 
studies [13] we have been able to identify signals 
from 2 of the 4 Trp, the 7 His and 5 Tyr residues 
and from 5 of the 8 Phe residues. Here, we describe 
how selective deuteration experiments now allow 
us to identify signals from all 8 Phe residues and 
how the resulting simplification of the 2D NOESY 
spectra can assist in their specific assignment. 
2. MATERIALS AND METHODS 
[2’,4’,5’,6’,7’-*H]Tryptophan (I), [3’,5’-*H]tyrosine (II) and 
[2’-‘Hlhistidine (III) were prepared from the unlabelled amino 
acids by methods described previously [I4]. [4’-*H]Phenyl- 
alanine (IV) was synthesized starting from p-bromotoluene. The 
hydrolysis of the Grignard Mg-complex ofp-bromotoluene with 
DzO gave p-deuterotoluene, which was then brominated using 
Brz in CCL under UV irradiation to give p-deuterobenzyl 
bromide. Thep-deuterobenzyl bromide in ethanol was added to 
a solution of sodium acetamidodiethylmalonate in absolute 
ethanol and the resulting p-deuterobenzyl acetamidodiethyl- 
malonate was hydrolyzed in HCI giving dl-p-deutero- 
phenylalanine HCI. The various methods of deuteration used 
resulted in some racemisation of the deuterated amino acids (ex- 
cept for Trp): they were used in subsequent fermentation with- 
out resolution. Lactobacillus casei was grown in defined 
medium which contained the deuterated amino acids (I-IV) to- 
gether with the other isotopically normal amino acids using the 
procedures described previously [5]. Dihydrofolate reductase 
was isolated from the L. casei cells and purified as described by 
Dann et al. [Ill. 
The non-deuterated ihydrofolate reductase was isolated 
from E. coli containing a plasmid bearing the L. casei dhfr gene 
(under the control of the X pL promoter 112)) and was purified 
in the same way as that used for the enzyme from L. casei. 
Methotrexate was obtained commercially (Sigma) and was 
used without further purification. 
‘H NMR spectra were obtained at 500 and 600 MHz using 
Bruker AM-500 and 600 spectrometers operating in the Fourier 
transform mode as described by Hammond et al. [13]. 
In some samples the exchangeable protons in the dihydro- 
folate reductase were replaced by deuterium by freeze-drying the 
enzyme from DtO solution. Enzyme samples were redissolved to 
form l-l.3 mM solutions in DzO containing 500 mM 
KC1/50 mM potassium phosphate at pH* 6.5 (meter eading un- 
corrected for the isotope effect on the glass electrode) before ad- 
ding one or more equivalents of methotrexate. The 3 mM 
enzyme-MTX sample was prepared by dialysing 1 mM enzyme 
in the presence of MTX and dilute buffer, which was then con- 
centrated by freeze-drying and redissolving in a smaller volume 
of DzO. 
3. RESULTS AND DISCUSSION 
Fig.la shows the aromatic region of the ‘H 
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Fig.2. The aromatic region of the resolution enhanced ‘H spectrum of the selectively deuterated ihydrofolate reductase-methotrexate 
comples (1.3 mM solution in D20 buffer) recorded at 600 MHz. The bars above the spectrum indicate the connected pairs of doublets 
from the 8 Phe residues. The chemical shift reference is dioxane (1 mM). 
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COSY spectrum of the complex of methotrexate 
with normal (non-deuterated) dihydrofolate reduc- 
tase. Analysis of this spectrum is not straightfor- 
ward and even when considered in conjunction 
with the HOHAHA and 2D double-quantum- 
coherence spectra it was only possible to detect 
cross-peaks for 5 of the 8 Phe residues. Fig.lb 
shows the COSY ‘H spectrum for the methotrexate 
complex with the selectively deuterated enzyme 
prepared by incorporating the aromatic amino 
acids I-IV. This pattern of deuteration was chosen 
so that only Phe residues will give cross-peaks in 
the aromatic region of the COSY spectrum (each 
expected to give a single cross-peak under condi- 
tions of rapid ring flipping). The dramatic 
simplification seen in fig. 1 b allows us to detect im- 
mediately signals from 7 of the 8 Phe residues. The 
absence of a cross-peak from one of ,the Phe 
residues could have resulted either from the cou- 
pled Phe protons having very similar chemical 
shifts or from line-broadening effects associated 
with some exchange process (such as ring flipping). 
Examination of the one-dimensional 600 MHz ‘H 
spectrum (see fig.2) clearly indicates that the 
former explanation is correct. In this spectrum it is 
possible to detect a strongly coupled AB multiplet 
at 3.64 ppm (from dioxan reference) in addition to 
the 7 pairs of doublets corresponding to the cross- 
peaks detected in the COSY spectrum. The sharp 
singlet signals seen in fig.2 can be assigned to the 
imidazole H4 protons of the 7 His and the H2’ and 
H6’ protons of the 5 Tyr residues. 
The sequence-specific assignment of the signals 
from the Phe residues requires correlating NOE 
connectivities between Phe protons and protons 
from other residues with internuclear distance in- 
formation obtained from the crystal structure [ 151. 
Using this approach we have already assigned 
signals from Phe 49, 103 and 122 [13] and these are 
indicated in fig.lb. Selective deuteration simplifies 
not only the COSY spectra but also the 2D NOESY 
spectra as can be seen by comparing the NOESY 
spectra of normal and deuterated enzyme com- 
plexes (see fig.3). Such simplification will clearly 
assist in making assignments by removing am- 
biguities in the origins of the NOESY cross-peaks. 
For example, the cross-peaks in the row at FI 
-4.71 ppm in fig.3a correspond to several 
aromatic signals with NOE connections to the 
previously assigned CH3 signal of Leu 113: fig.3b 
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Fig.3. Selected regions of the ‘H NMR NOESY spectra of the 
dihydrofolate reductase-methotrexate complex. Spectrum (a) 
obtained with non-deuterated enzyme showing, (top) the 
NOESY peaks connecting aliphatic protons and aromatic pro- 
tons and (bottom) the aromatic protons with other aromatic 
protons. Spectrum (b) shows the same regions obtained from 
the deuterated nzyme sample. NOESY spectra were obtained in 
the phase-sensitive mode using a (90-ti-9O-~m-9O-t2-d)n se- 
quence and the method of time-proportional phase incrementa- 
tion [17,18]. Additional phase cycling was used to reduce 
quadrature images and axial peaks. 2048 data points were 
recorded in tz for each free induction decay. The time-domain 
data from a NOESY experiment was zero-filled to 1024 points in 
I~ and processed with a sine bell function in each dimension, 
shifted r/32 in t2 and a/l6 in I,. In spectrum (a) 320 scans were 
acquired for each of the 256 tl values. The spectral width was 
7042 Hz (14.5 ppm) giving a digital resolution of 3.5 Hz/point 
in Fz. The mixing time was 0.15 s. The enzyme-methotrexate 
complex was 3.0 mM in DzO in 50 mM potassium phosphate/ 
500 mM KC1 and the spectrum was recorded at 298 K. In spec- 
trum (b) 272 scans were acquired for each of the 384 tl values. 
The spectral width was 6410 Hz (12.8 ppm) giving a digital 
resolution of 3.1 Hz/point in Fz. The mixing time was 0.1 s. 
The enzyme-methotrexate complex was 1 .O mM in D20 buffer 
and the spectrum was recorded at 308 K. 
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indicates that for the deuterated enzyme there are 
now only two NOE cross-peaks in this region. Con- 
sideration of the crystal structure data reveals that 
Phe 136 is the only Phe residue which is close 
enough to Leu 113 to provide these NOE interac- 
tions thus allowing us to assign the corresponding 
signals for Phe 136. The additional cross-peaks 
seen at FI -4.71 ppm in fig.3a arise from NOE 
connections between Trp ring protons and Leu 113 
CH3 thus allowing further assignments to be made. 
The spectral simplification seen in the columns of 
cross-peaks at each F2 value can also assist in the 
assignment. This is seen very clearly in the com- 
parison of the columns of cross-peaks at FZ 
3.78 ppm in fig.3a,b; the cross-peaks at FI 0.47, 
- 0.41 and - 0.88 ppm in fig.3b can be assigned to 
the Phe 122 cy, p, p’ protons, respectively, from 
NOE interactions with H2’,6’ of Phe 122. 
The ultimate success of these assignment 
methods based on combining selective deuteration 
with 2D NMR techniques will depend on carefully 
choosing the extent of deuteration to provide suffi- 
cient spectral simplification to remove chemical 
shift degeneracy while retaining enough protons to 
give an adequate number of NOE connectivities. 
The study of such deuterated proteins purified 
from organisms grown on carefully selected 
deuterated amino acids promises to become a 
routine approach for aiding assignments in the 
NMR spectra of large proteins. 
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